Skip to content
Review Open access

Obesity and chronic kidney disease: a cardio-kidney-metabolic framework for renal vulnerability and risk stratification.

Sep 2026 · Nephrology, Dialysis and Transplantation · 0 citations
Medicine

TL;DR

A conceptual framework comprising four overlapping CKM-related kidney vulnerability domains is proposed, which may help identify individuals at increased CKD risk, support earlier screening and longitudinal monitoring, and inform preventive strategies.

Abstract

Obesity is an important risk factor for chronic kidney disease (CKD), yet only a subset of individuals with obesity develops albuminuria, declining estimated glomerular filtration rate (eGFR), and progressive kidney disease. This variability indicates that excess body weight alone is insufficient to explain obesity-induced kidney injury. In this review, we propose that cardio-kidney-metabolic (CKM) syndrome provides a useful framework to understand this heterogeneity. We discuss major pathophysiological contributors to kidney vulnerability in obesity, including haemodynamic stress, metabolic toxicity/insulin resistance, visceral and ectopic fat, inflammation, oxidative stress, adipokine imbalance, and reduced nephron reserve. Several of these contributors converge on a common intrarenal pathway characterized by increased single-nephron workload, maladaptive glomerular hyperfiltration and intraglomerular hypertension, followed by podocyte stress, albuminuria, and progressive kidney injury. On this basis, we propose a conceptual framework comprising four overlapping CKM-related kidney vulnerability domains, which may help identify individuals at increased CKD risk, support earlier screening and longitudinal monitoring, and inform preventive strategies.

Read PDF

Similar papers

Review Sep 2026

Obesity and Cardio-Metabolic Health in Kidney Disease: Implications for Kidney Health, Risk Stratification, and Management.

Obesity is a major risk factor for chronic kidney disease (CKD), which contributes to a complex interplay of metabolic, inflammatory, and hemodynamic disturbances that accelerate kidney function decline and heighten cardiovascular risk. Obesity contributes to kidney injury through direct mechanisms, including glomerula...

Roy O. Mathew, An-Nie Hong, Y. Narasaki et al. · 0 citations
Review Open access Sep 2026

Chronic kidney disease as a systemic disorder: filtration phenotypes, inflammation and cardiovascular risk in the cardio-kidney metabolic era.

Chronic kidney disease (CKD) is increasingly recognized as a systemic disorder driven by metabolic dysfunction, vascular injury, inflammation, and emerging filtration phenotypes. In the cardio-kidney-metabolic (CKM) era, renal biomarkers such as estimated glomerular filtration rate (eGFR) and albuminuria provide essent...

R. Valtuille, E. Fernández · 0 citations
Review Open access Sep 2026

CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH CHRONIC KIDNEY DISEASE

Chronic kidney disease is a major cardiovascular risk state in which conventional risk factors coexist with renal -specific mechanisms that promote vascular injury, myocardial remodeling, thrombosis, and arterial calcification. The cardiovascular burden becomes progressively greater as kidney function declines and is a...

Ulykbek Daurenov, Assiya Sherkhan, Sanzhar Mereyuly et al. · 0 citations
Review Open access Oct 2026

Cardiovascular-kidney-metabolic syndrome and type 2 diabetes mellitus: from risk stratification to multidisciplinary patient management

Type 2 diabetes mellitus (T2DM) is a key component of cardiovascular-kidney-metabolic (CKM) syndrome, an interconnected complex of metabolic disorders, chronic kidney disease (CKD), and cardiovascular disease (CVD). T2DM is characterized by chronic hyperglycemia resulting from insulin resistance and progressive impairm...

T. Demidova, M. Izmailova · 0 citations
Review Open access Oct 2026

Biomarkers for the diagnosis and management of cardiovascular-kidney-metabolic syndrome: recent advances and prospects for clinical application

Cardiovascular-kidney-metabolic (CKM) syndrome describes a multidirectional network linking dysfunctional adiposity, metabolic risk factors, kidney disease and cardiovascular injury. Its early stages are often clinically silent, while obesity, impaired kidney function, multimorbidity and recent exercise can alter the c...

Liu-Qi Hu, Min Yang · 0 citations
Review Sep 2026

Atherosclerotic Cardiovascular Disease in CKD: Contemporary Insights into Pathogenesis, Diagnosis, and Management.

Patients with chronic kidney disease (CKD) have a disproportionate burden of cardiovascular disease, and the majority die from cardiovascular causes before ever reaching kidney failure. Atherosclerotic cardiovascular disease (ASCVD), which includes coronary artery disease, cerebrovascular disease, and peripheral arteri...

Simon Correa, Jonathan W. Cuningham, F. M. Mc Causland · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.